SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for ... - PR Newswire (press release)

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for ... PR Newswire (press release) In Phase 3 rheumatoid arthritis trials, SIMPONI was shown to be effective regardless of prior treatment experience, which included patients inadequately ... and more »

White House: 7 years enough to shield biotech drugs - Reuters

Macon Daily

White House: 7 years enough to shield biotech drugs Reuters The drugs treat conditions ranging from anemia and rheumatoid arthritis to cancer. Waxman, chairman of the House of Representatives Energy and Commerce ... Biotech Drugs Need Only 7 Years Protection, US SaysBloomberg all 31 news articles »

BUYINS.NET: ARM, CAST, BIOS, NCS, LZB, THC. Top Gainers With ... - Trading Markets (press release)

BUYINS.NET: ARM, CAST, BIOS, NCS, LZB, THC. Top Gainers With ... Trading Markets (press release) ... and bleeding disorders/hemophilia; multiple sclerosis and neuropathies; in office infusions and oral oncolytics; rheumatoid arthritis, osteoarthritis, ... and more »

Diseases turn the body against itself - Joliet Herald News

Diseases turn the body against itself Joliet Herald News Some of the autoimmune diseases rheumatologists like Sosenko treats include rheumatoid arthritis, lupus, scleroderma, and vasculitis. ... and more »